Jinxing Fu

Prof. Jinxing Fu

Department of Hematology, the Second Affiliated Hospital of Soochow University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Cancer Letters
Verified
Journal Article
Closed access
BWBo Wang
Bo Wang
JMJia-Hui Mao
Jia-Hui Mao
BWBing-Ying Wang
Bing-Ying Wang
LWLing-Xia Wang
Ling-Xia Wang
HWHui-Yan Wen
Hui-Yan Wen
HYHuan Yang
Huan Yang

28 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
RYRu Yang
Ru Yang
YZYingzi Zhang
Yingzi Zhang
LWLin Wang
Lin Wang
JHJi Hu
Ji Hu
JWJian Wen
Jian Wen
JFJinxing Fu
Jinxing Fu
Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis

18 November 2016 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
BWBo Wang
Bo Wang
HYHuan Yang
Huan Yang
LSLiqin Shen
Liqin Shen
JWJi Wang
Ji Wang
WPWangyang Pu
Wangyang Pu
ZZZhixiang Zhuang
Zhixiang Zhuang
Background/Aims: Interferon regulatory factor 1 (IRF-1) has been shown to function as a transcriptional activator or repressor of a variety of target genes. However, its upstream, non-coding RNA-related regulatory capacity remains unknown. In this study, we focus on the miRNA-associated single nucleotide polymorphisms (SNPs) in the 3′untranslated region (UTR) of IRF-1 to further investigate the functional relationship and potential diagnostic value of the SNPs and miRNAs among Chinese gastric cancer (GC) patients. Methods: We performed a case-control study with 819 GC patients and 756 cancer-free controls. Genotyping by realtime PCR assay, cell transfection, and the dual luciferase reporter assay were used in our study, and the 5-year overall survival rate and relapse-free survival rate in different groups were investigated. Results: We found that patients suffering from Helicobacter pylori (Hp) infection were the susceptible population compared to controls. SNP rs56288038 (C/G) in IRF-1 3′UTR was involved in the occurrence of GC by acting as a tumor promoter factor. SNP rs56288038 (C/G) could be up-regulated by miR-502-5p, which caused a down-regulation of IRF-1 in cell lines and decreased apoptosis induced by IFN-γ. Carrying the G genotype was related to significantly low expression of IRF-1 and Hp infection, poor differentiation, big tumor size, invasion depth, as well as the high probability of metastasis, and moreover, the C/G SNP was associated with shorter survival of GC patients with five years of follow-up study. Conclusions: our findings have shown that the SNP rs56288038 (C/G) in IRF-1 3′UTR acted as a promotion factor in GC development through enhancing the regulatory role of miR-502-5p in IRF-1 expression.

1 January 2017 in Archives of Medical Science
Verified
Journal Article
Open access
PDF file
JFJinxing Fu
Jinxing Fu
Introduction: Connexin-43 (Cx43), a connexin constituent of gap junctions (GJs) is mainly expressed in bone marrow stromal cells (BMSCs) and played a important role on hematopoiesis. In this study, we explored the role of gap junctions (GJs) formed by Cx43 between BMSCs and multiple myeloma...

1 March 2021 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
LXLeixi Xue
Leixi Xue
YZYi Zhang
Yi Zhang
JXJiajun Xu
Jiajun Xu
WLWentian Lu
Wentian Lu
QWQing Wang
Qing Wang
ZLZhichun Liu
Zhichun Liu
Purpose: Current studies on the mechanism of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in lupus nephritis (LN) mainly focus on the inflammatory pathway. Herein, we aimed to determine whether TWEAK could promote the progression of renal interstitial fibrosis by regulating peroxisome proliferator-activated receptor-gamma coactivator-1α (PGC-1α) expression and intervening in lipid metabolism in LN. Materials and Methods: MRL/lpr mice, an animal model of lupus, were treated with the anti-TWEAK antibody or co-treated with adeno-associated virus-mediated PGC-1α short hairpin RNA (shRNA). In addition, human proximal tubular epithelial cells (HK2 cells) were treated with recombinant human TWEAK (rhTWEAK) or ammonium pyrrolidine dithiocarbamate (PDTC) in vitro. Results: The renal contents of free fatty acids and triglycerides were higher in MRL/lpr mice than in MRL/MpJ mice; however, these contents were decreased by treatment with the anti-TWEAK antibody. Based on immunofluorescence staining, the expression of PGC-1α was markedly more in the renal tubules of MRL/MpJ mice than in the glomeruli. However, treatment with anti-TWEAK antibody increased the levels of PGC-1α and its downstream target genes, which were remarkably lower in MRL/lpr mice than in MRL/MpJ mice. Anti-TWEAK antibody effectively eased renal interstitial fibrosis, which manifested as a decrease in the deposition of collagen fibers and the inhibition of type I collagen and fibronectin expression. However, the therapeutic effects of the anti-TWEAK antibody were abolished by PGC-1α shRNA. Treatment with rhTWEAK decreased PGC-1α expression in both dose- and time-dependent manners in HK2 cells in vitro. PDTC, an inhibitor of IκBα phosphorylation, suppressed the decrease in the PGC-1α protein level induced by rhTWEAK treatment. Conclusion: Our results suggest that TWEAK prevents renal tubular PGC-1α expression by promoting NF-κB activation, resulting in a deficiency in lipid metabolism and the progress of renal interstitial fibrosis. The upregulation of renal tubular PGC-1α expression to improve lipid metabolism is one of the mechanisms employed by the anti-TWEAK antibody to treat renal interstitial fibrosis.

24 July 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
ZWZiyan Wang
Ziyan Wang
YYYuqing Yuan
Yuqing Yuan
LZLiying Zhang
Liying Zhang
ZMZhou Min
Zhou Min
DZDongming Zhou
Dongming Zhou
JFJinxing Fu
Jinxing Fu
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Ziyan Wang1, *, Yuqing Yuan1, *, Liying Zhang1, *, Zhou Min1, Dongming Zhou1, Sun Yu1, Panjun Wang1, Songguang Ju2, Li Jun1 and Jinxiang Fu1 1Hematology Department, The Second Affiliated Hospital of Soochow University, Suzhou 215004, PR China 2Institute of Biotechnology, Soochow University, Suzhou 215007, PR China *These authors contributed equaly to this work Correspondence to: Jinxiang Fu, email: fjx3000@126.com Keywords: multiple myeloma; bone marrow microenvironment; mesenchymal stem cell; cell fusion; chemoresistance Received: December 27, 2017 Accepted: June 05, 2018 Published: July 24, 2018 ABSTRACT Background: Mesenchymal stem cells (MSCs) represent a subset of non-hematopoietic adult stem cells, which can also fuse with other cells spontaneously in bone marrow and capable of adopting the phenotype of other cells. The fusion of somatic cells with stem cells can reprogram somatic cells to a pluripotent state. Our research on the fusion of bone marrow mesenchymal stem cells(BM-MSCs) and MM cells demonstrate that the fused cells can exhibit stemness and cancer cell-like characteristics. Results: We successfully produced a hybrid cells that acquired larger size and multinucleation, in which partial chromatin condensation, a visible nucleolus, and one or more round or oval nucleus. Experiments results showed that the stemness markers highly expressed in these fused cells and there were much more chromosomes in fused cells than those in parental cells as well as exhibited increased resistance to drug treatment. Conclusions: Our results suggest that cell fusion between BM-MSCs and MM cells could contribute it genomic heterogeneity and play a role on disease progression. Methods: We fused human BM-MSCs with MM cells lines RPMI 8226 or XG1 in vitro by polyethylene glycol (PEG), and the hybrid cells were sorted by sedimentation assays. The growth, migration, cell cycle, chromosome and drug sensitive of hybrids were assessed by cell counting, cell colony formation, transwell assays, cytogenetic assay and flow cytometry (FCM). The proteins and genes related to stemness and cytokines were tested by western blot and/or real-time quantitative RT-PCR.